Deep Competitors

Delisted . USA . 
Stock . Deep Medicine Acquisition
DMAQDelisted Stock  USD 11.59  0.12  1.02%   
Deep Medicine Acquisition competes with BurTech Acquisition, AlphaVest Acquisition, Insight Acquisition, ClimateRock, and Alpha One; as well as few others. The company conducts business under Capital Markets sector and is part of Financials industry. Analyzing Deep Medicine competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Deep Medicine to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Deep Medicine competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
11.5911.5911.59
Details
Intrinsic
Valuation
LowRealHigh
9.849.8412.75
Details
Naive
Forecast
LowNextHigh
11.5811.5811.58
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
11.5511.6111.67
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Deep Medicine. Your research has to be compared to or analyzed against Deep Medicine's peers to derive any actionable benefits. When done correctly, Deep Medicine's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Deep Medicine Acquisition.

Deep Medicine Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Deep Medicine and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Deep and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Deep Medicine Acquisition does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ATMV
+ 0.92
BRKH
CLRC
+ 0.9
ATMV
CLRC
+ 0.88
BRKH
ATMV
+ 0.81
AVHI
AVHI
+ 0.79
BRKH
CLRC
+ 0.66
AVHI
  
High negative correlations   
KWAC
- 0.53
AVHI
INAQ
- 0.38
ATMV
KWAC
- 0.38
USCT
INAQ
- 0.33
ACAC
KWAC
- 0.32
INAQ
KWACW
- 0.28
USCT

Risk-Adjusted Indicators

There is a big difference between Deep Stock performing well and Deep Medicine Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Deep Medicine's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ACAC  2.20  0.13 (0.01)(0.07) 3.84 
(3.68)
 12.07 
(10.16)
 30.82 
BRKH  0.11  0.02 (0.46) 1.55  0.00 
(0.21)
 0.44 
(0.26)
 0.88 
CDAQ  0.15  0.00  0.00  0.16  0.00 
 0.00 
 0.19 
(0.73)
 4.23 
USCT  0.13  0.00 (0.27) 0.22  0.19 
(0.54)
 0.38 
(0.47)
 2.37 
AVHI  0.18  0.01 (0.17)(0.98) 0.22 
(0.41)
 0.56 
(0.56)
 2.61 
ATMV  0.04  0.00  0.00  0.00  0.00 
 0.00 
 0.09 
 0.00 
 0.27 
KWACW  52.43  18.33  0.45  5.36  29.03 
(93.04)
 161.33 
(62.22)
 749.43 
INAQ  2.19  0.20 (0.01)(0.05) 4.73 
(3.21)
 7.60 
(5.60)
 38.96 
KWAC  0.38  0.01  0.00  0.15  0.00 
 0.00 
 1.89 
 0.00 
 10.08 
CLRC  0.02  0.00  0.00 (0.28) 0.00 
 0.00 
 0.00 
 0.00 
 0.43 
All Fundamental Data

Deep Medicine Competitive Analysis

The better you understand Deep Medicine competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Deep Medicine's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Deep Medicine's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
DMAQ ACAC BRKH CDAQ USCT AVHI ATMV KWACW INAQ KWAC
 1.02 
 11.59 
Deep
 0.82 
 10.90 
Acri
 0.09 
 11.41 
BurTech
 0.00 
 10.74 
Compass
 0.00 
 10.51 
TKB
 0.00 
 10.65 
Achari
 0.18 
 11.25 
AlphaVest
 0.00 
 0.01 
Kingswood
 4.94 
 10.84 
Insight
 0.00 
 10.80 
Kingswood
Market Volatility
(90 Days Market Risk)
Very steady
Relatively risky
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Slightly risky
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Good
Very Weak
Very Weak
Very Weak
Strong
Very Weak
Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Dangerous
Above Average
Dangerous
Dangerous
Dangerous
Below Average
Dangerous
High
Dangerous
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Not Rated
Cautious Hold
Not Rated
Not Rated
Not Rated
Strong Buy
Not Rated
Strong Sell
Not Rated
Current Ratio
229.55
N/A
4.41
13.89
3.3
2.3
N/A
N/A
5.15
0.08
Net Asset
9.78 M
36.73 M
72.59 M
55.43 M
23.53 M
6.15 M
50.94 M
118.83 M
12.35 M
119.6 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
EBITDA
(3.99 M)
(801.15 K)
5.75 M
(2.05 M)
(4.42 M)
(3.18 M)
2.9 M
N/A
76.3 K
(1.21 M)
Current Valuation
15.74 M
46.98 M
174.51 M
83.72 M
71.49 M
33.85 M
79.69 M
N/A
70.8 M
47.46 M
Price To Book
22.01
2.87
5.83
1.53
4.09
7.61
1.52
N/A
3.81
5.92
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Retained Earnings
(6.44 M)
(4.64 M)
(15.84 M)
(1.37 M)
(8.96 M)
(7.73 M)
(325.05 K)
N/A
(11.5 M)
N/A
Current Asset
N/A
N/A
N/A
N/A
N/A
81.02 M
N/A
N/A
N/A
N/A
Beta
0.017
0.034
0.036
0.005
0.002
0.053
N/A
N/A
-0.019
N/A
Number Of Employees
2
1
N/A
4
11
17
N/A
3
N/A
3
Shares Outstanding
4.36 M
1.82 M
15.16 M
5.68 M
7.79 M
3.05 M
7.01 M
N/A
5.62 M
1.46 M
Cash Flow From Operations
(1.04 M)
(849.99 K)
(2.34 M)
(1.18 K)
(862.99 K)
(1.04 M)
(630.48 K)
N/A
(2.91 M)
(619.36 K)
Total Debt
1.86 M
1.43 M
810.35 K
125 K
682.51 K
582 K
165 K
N/A
12.49 M
390.71 K
Return On Equity
N/A
N/A
N/A
N/A
N/A
N/A
0.25
N/A
N/A
N/A
Z Score
2.74
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
71.4
Return On Asset
-0.0176
-0.0233
-0.0328
-0.0253
-0.0211
-0.077
-0.0078
N/A
-0.12
-0.0063
Number Of Shares Shorted
10.3 K
13.09 K
4.25 K
452
3.45 K
1.97 K
3.79 K
N/A
9.31 K
6.92 K
Book Value Per Share
-1.69
-1.39
-1.04
-0.17
-0.23
-2.53
-0.046
-0.47
-1.57
-1.64
Current Liabilities
N/A
N/A
N/A
N/A
N/A
59.96 M
N/A
N/A
N/A
N/A
Total Asset
9.78 M
36.73 M
72.59 M
55.43 M
23.53 M
6.15 M
50.94 M
118.83 M
12.35 M
119.6 M
Short Ratio
0.33
0.61
0.38
0.02
0.06
3.12
0.51
N/A
1.13
2.36
Debt To Equity
N/A
9.67
0.004
N/A
N/A
1.76
N/A
N/A
N/A
N/A
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
28.73
7.17
31.52
91.53
25.87
16.92
65.51
N/A
7.33
90.86
Market Capitalization
12.9 M
44.48 M
173.01 M
83.68 M
77.59 M
33.35 M
78.82 M
N/A
70.67 M
46.85 M
Price To Earning
N/A
N/A
N/A
N/A
N/A
21.23
N/A
N/A
N/A
6.6
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
0.84
N/A
N/A
N/A
N/A
Price To Sales
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
(400.23 K)
886.37 K
1.34 M
4.39 K
2.59 M
(2.57 M)
2.9 M
N/A
(651.14 K)
(445.74 K)
Earnings Per Share
-0.13
-0.62
-0.15
-0.38
0.23
-0.77
0.37
N/A
-0.46
0.65
Shares Owned By Insiders
74.08
N/A
68.49
43.43
65.06
51.53
30.37
N/A
N/A
N/A
Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Working Capital
6.98 M
(2.49 M)
(5.68 M)
299.07 K
(1.29 M)
(4.13 M)
(324.82 K)
N/A
(3.57 M)
N/A
Cash And Equivalents
707.98 K
1.08 M
621.58 K
1.23 M
355.24 K
379.17 K
N/A
N/A
126.5 K
139.93 K
Cash Per Share
0.04
0.1
0.02
0.05
0.01
0.03
N/A
N/A
N/A
0.03
Gross Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Day Typical Price
11.7
10.6
11.41
10.74
10.51
10.65
11.25
0.0082
11.11
10.8
Accumulation Distribution
0.0343
0.1
9.0E-4
N/A
N/A
N/A
N/A
N/A
0.33
N/A
Market Facilitation Index
0.41
1.14
0.01
N/A
N/A
N/A
N/A
N/A
4.49
N/A
Daily Balance Of Power
(0.29)
(0.08)
1.0
0.0
0.0
0.0
9.2 T
0.0
0.1136
0.0
Period Momentum Indicator
(0.12)
(0.09)
0.01
N/A
N/A
N/A
0.02
N/A
0.51
N/A
Rate Of Daily Change
0.99
0.99
1.0
1.0
1.0
1.0
1.0
1.0
1.05
1.0
Day Median Price
11.76
10.45
11.41
10.74
10.51
10.65
11.25
0.0082
11.25
10.8
Price Action Indicator
(0.23)
0.41
0.01
N/A
N/A
N/A
0.01
N/A
(0.15)
N/A
Relative Strength Index
99.97
54.15
56.34
58.37
82.12
99.46
99.28
30.2
70.22
0.0052
Coefficient Of Variation
1224.37
8694.55
566.19
(14,893)
16255.71
1546.53
280.32
569.13
7575.83
2014.3
Mean Deviation
0.951
2.2
0.1107
0.1489
0.1293
0.1782
0.038
52.43
2.19
0.3822
Jensen Alpha
0.1656
0.1303
0.0181
(0)
(0)
0.0136
N/A
18.33
0.2037
0.0107
Total Risk Alpha
(0.15)
(0.74)
(0.01)
(0.09)
(0.06)
(0.04)
6.0E-4
1.94
(0.73)
(0.15)
Sortino Ratio
0.0104
(0.01)
(0.46)
N/A
(0.27)
(0.17)
N/A
0.4499
(0.01)
N/A
Downside Variance
4.99
41.72
0.0493
N/A
0.2226
0.393
N/A
1715.73
58.94
N/A
Standard Deviation
1.89
4.98
0.1678
0.4691
0.3122
0.3413
0.0532
106.79
4.98
1.34
Kurtosis
8.22
5.65
2.35
21.39
10.21
6.11
2.44
27.07
9.63
23.19
Potential Upside
3.19
12.07
0.4421
0.1857
0.381
0.5634
0.09
161.33
7.6
1.89
Treynor Ratio
(0.80)
(0.07)
1.55
0.161
0.2172
(0.98)
N/A
5.36
(0.05)
0.1492
Maximum Drawdown
13.78
30.82
0.882
4.23
2.37
2.61
0.2691
749.43
38.96
10.08
Variance
3.56
24.8
0.0282
0.2201
0.0975
0.1165
0.0028
11404.69
24.76
1.79
Market Risk Adjusted Performance
(0.79)
(0.06)
1.56
0.171
0.2272
(0.97)
N/A
5.37
(0.04)
0.1592
Risk Adjusted Performance
0.0686
0.0173
0.0998
(0.01)
(0.01)
0.0371
0.1395
0.1447
0.0186
0.0423
Skewness
1.48
0.8302
0.7883
2.28
1.8
(0.09)
1.26
4.71
(1.24)
(0.89)
Semi Deviation
1.14
3.84
0.0
N/A
0.1926
0.2196
N/A
29.03
4.73
N/A
Information Ratio
0.0123
(0.01)
(0.60)
(0.29)
(0.41)
(0.32)
(2.10)
0.1745
(0.01)
(0.05)
Value At Risk
(1.79)
(10.16)
(0.26)
(0.73)
(0.47)
(0.56)
N/A
(62.22)
(5.60)
N/A
Expected Short fall
(1.80)
(3.68)
(0.21)
N/A
(0.54)
(0.41)
N/A
(93.04)
(3.21)
N/A
Downside Deviation
2.23
6.46
0.2221
N/A
0.4718
0.6269
N/A
41.42
7.68
N/A
Semi Variance
1.3
14.77
(0.02)
N/A
0.0371
0.0482
N/A
842.56
22.38
N/A

Deep Medicine Competition Performance Charts

Five steps to successful analysis of Deep Medicine Competition

Deep Medicine's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Deep Medicine Acquisition in relation to its competition. Deep Medicine's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Deep Medicine in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Deep Medicine's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Deep Medicine Acquisition, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Deep Medicine position

In addition to having Deep Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Biotech Thematic Idea Now

Biotech
Biotech Theme
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in Deep Stock

If you are still planning to invest in Deep Medicine Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deep Medicine's history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY